W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number TGMR313120J |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
Pseudoaneurysm (2605)
|
Event Date 09/13/2022 |
Event Type
Death
|
Manufacturer Narrative
|
Code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
On (b)(6) 2021, a patient underwent endovascular treatment of a thoracic aortic disease using gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgm343420j.The patient had already undergone a total arch replacement and a frozen elephant trunk.The ctagac was implanted to extend distally from the elephant trunk.On unknown date, but in (b)(6) 2022, a pseudoaneurysm was observed at the distal end of the ctagac.On (b)(6) 2022 reintervention was performed to treat the pseudoaneurysm.A gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgmr313120j, was implanted distally.A proximal type i endoleak of tgmr313120j was observed.To treat it, additionally gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgm343415j, was implanted proximally.A minor proximal type i endoleak remained at an outer curvature.The physician decided to monitor it.The patient tolerated the procedure.((b)(4)) on (b)(6) 2022, new pseudoaneurysm was observed at the distal end of the ctagac #tgm313120j.On (b)(6) 2022, the pseudoaneurysm ruptured.Unable to treat, the patient passed away.The physician stated that he thought that the device, tgm313120j, was the right size, but the cause was unknown.Reportedly, a semi-emergency thoracic endovascular aortic repair was scheduled for (b)(6) 2022.
|
|
Manufacturer Narrative
|
Emdr section h6 codes were updated to reflect the result(s) of the investigation.
|
|
Search Alerts/Recalls
|
|
|